Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.

Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...

Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...

A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...

A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...

Over seven years, those taking medication such as Ozempic and Mounjaro - were less likely to develop these brain issues or die prematurely. But Edinburgh University's Professor Tara Spires-Jones told ...